Symptoms & the Spectrum of DNAJC12 Deficiency
At a Glance
DNAJC12 deficiency has a broad, unpredictable spectrum: some people only have elevated phenylalanine and remain healthy, while others develop developmental, behavioral, psychiatric, or movement symptoms in childhood or adulthood. Ongoing monitoring helps identify support needs.
DNAJC12 deficiency is known as a spectrum disorder, meaning it affects every person differently. Some individuals may have no symptoms at all (asymptomatic), while others may experience significant challenges with movement or learning [1][2].
Crucially, the severity of the condition can vary even within the same family. Two siblings with the exact same genetic mutation might have very different experiences: one might only have minor speech delays, while the other could have more complex movement difficulties [3][4]. Because this condition involves the brain’s supply of dopamine and serotonin, reported symptoms can evolve over time, though the available data cannot provide a reliable individual prognosis.
Infancy: The First Clues
For most babies, the first sign of DNAJC12 deficiency is a slightly high level of phenylalanine on a newborn screening test [5][6]. At this stage, many infants appear perfectly healthy. When early symptoms do occur, they have been reported to include:
- Hypotonia: Often described as “floppiness” or low muscle tone [7].
- Mild Developmental Delays: A baby might take longer than average to hold their head up, sit, or roll over [7].
- Subtle Communication Gaps: By late infancy or early toddlerhood, parents may notice slight differences in how the child interacts or responds to social cues [6].
Childhood: Learning and Behavior
As children reach school age, reported associations focus more on how the brain processes information and social connections.
- Speech and Language Impairment: This is one of the more common symptoms reported, where a child may struggle with forming sentences or understanding complex instructions [6][3].
- Neurodevelopmental Features: Some children show associations with Autism Spectrum Disorder (ASD) traits or ADHD-like hyperactivity [1][5]. (These should be formally assessed and supported with standard educational and behavioral therapies on their own merits).
- Intellectual Disability: In some cases, individuals experience broader learning challenges or intellectual disabilities [2][1].
- Early Coordination Issues: You might notice your child is “clumsy,” has frequent falls, or develops a slight tremor (shaking) in their hands [3].
Adolescence and Adulthood: Movement Changes
In the teenage years and beyond, some individuals in published case reports have developed motor system issues. This timeline is not inevitable, but reported possibilities include:
- Dystonia: This involves involuntary muscle contractions that cause repetitive or twisting movements [2][3].
- Parkinsonism: This term describes symptoms that look like Parkinson’s disease, such as muscle stiffness, slow movements, and a “shuffling” walk [2][8].
- Psychiatric Symptoms: Some adults may experience mood disorders or psychiatric challenges that require specialized support [2].
- Late-Onset Symptoms: Some adults who were healthy as children have developed movement problems in their 20s or 30s. These are often levodopa-responsive, meaning they may improve with specific medication [2][8].
Understanding the Spectrum
It is important to know that not everyone follows a path toward severe symptoms. Researchers have identified a group of individuals who have the genetic markers for DNAJC12 deficiency but remain healthy into adulthood, with their only finding being elevated phenylalanine levels [2][9].
Standard developmental, educational, and mental-health assessments are essential tools for tracking growth and providing support, regardless of whether a symptom is directly caused by the metabolic diagnosis.
Common questions in this guide
What are the earliest signs of DNAJC12 deficiency?
Can DNAJC12 deficiency affect speech, learning, or behavior?
Will everyone with DNAJC12 deficiency develop movement problems?
Can two siblings with the same DNAJC12 variant have different symptoms?
What movement changes should families watch for as a child gets older?
Does an early DNAJC12 diagnosis predict how severe symptoms will be?
Get notified when new evidence is published on Hyperphenylalaninemia due to DNAJC12 deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias.
Blau N, Martinez A, Hoffmann GF, Thöny B
Molecular genetics and metabolism 2018; (123(1)):1-5 doi:10.1016/j.ymgme.2017.11.005.
PMID: 29174366 - 2
DNAJC12 Disease: Clinical Spectrum and Long-Term Outcomes.
Manti F, Ricciardi G, Nardecchia F, et al.
Neurology. Genetics 2026; (12(1)):e200335 doi:10.1212/NXG.0000000000200335.
PMID: 41450729 - 3
DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings.
Fino E, Barbato A, Scaturro GM, et al.
Molecular genetics and metabolism reports 2023; (37()):101008 doi:10.1016/j.ymgmr.2023.101008.
PMID: 38053929 - 4
A rare cause of hyperphenylalaninemia: four cases from a single family with DNAJC12 deficiency.
Gunes D, Senturk L
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(8)):791-797 doi:10.1515/jpem-2023-0049.
PMID: 37283250 - 5
Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.
Wong RSH, Mohammad S, Parayil Sankaran B, et al.
Brain & development 2023; (45(9)):523-531 doi:10.1016/j.braindev.2023.04.004.
PMID: 37156708 - 6
DNAJC12 Deficiency, an Emerging Condition Picked Up by Newborn Screening: A Case Illustration and a Novel Variant Identified.
Wong TS, Wong SSN, Kwok AMK, et al.
International journal of neonatal screening 2024; (10(4)) doi:10.3390/ijns10040074.
PMID: 39584997 - 7
DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variant.
Çıkı K, Yıldız Y, Yücel Yılmaz D, et al.
Metabolic brain disease 2021; (36(6)):1405-1410 doi:10.1007/s11011-021-00753-0.
PMID: 34014443 - 8
DNAJC12 and dopa-responsive nonprogressive parkinsonism.
Straniero L, Guella I, Cilia R, et al.
Annals of neurology 2017; (82(4)):640-646 doi:10.1002/ana.25048.
PMID: 28892570 - 9
Identification of two novel DNAJC12 gene variants in a patient with mild hyperphenylalaninemia.
Wang L, Ma D, Sun Y, et al.
Gene 2023; (869()):147397 doi:10.1016/j.gene.2023.147397.
PMID: 36990253
This page describes reported symptoms and variability in DNAJC12 deficiency for informational purposes only and does not constitute medical advice. It cannot predict an individual’s course; discuss developmental, behavioral, or movement concerns with a qualified healthcare professional.